AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland

• Hanna Nohynek ,

  * E-mail: hanna.nohynek@thl.fi

  Affiliation Department of Vaccines and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland

  ⨯
• Jukka Jokinen,

  Affiliation Department of Vaccines and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland

  ⨯
• Markku Partinen,

  Affiliation Helsinki Sleep Clinic, Vitalmed Research Centre, Helsinki, Finland

  ⨯
• Outi Vaarala,

  Affiliation Department of Vaccines and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland

  ⨯
• Turkka Kirjavainen,

  Affiliation Department of Pediatrics, Children's Hospital, Helsinki University Hospital, Helsinki, Finland

  ⨯
• Jonas Sundman,

  Affiliation Department of Vaccines and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland

  ⨯
• Sari-Leena Himanen,

  Affiliation Department of Clinical Neurophysiology, Tampere University Hospital, Tampere, Finland

  ⨯
• Christer Hublin,

  Affiliation Finnish Institute of Occupational Health, Helsinki, Finland

  ⨯
• Ilkka Julkunen,

  Affiliation Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Helsinki, Finland

  ⨯
• Päivi Olsén,

  Affiliation Department of Child Neurology, Oulu University Hospital, Oulu, Finland

  ⨯
• Outi Saarenpää-Heikkilä,

  Affiliation Department of Pediatrics, Tampere University Hospital, Tampere, Finland

  ⨯
• Terhi Kilpi

  Affiliation Department of Vaccines and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland

  ⨯